Clinical investigations demonstrate that GLP-1RA therapy exhibits superior therapeutic efficacy in patients without hepatic steatosis compared to those with fatty liver disease [42]
Yang J, Huang J, Dasgupta M, Sears N, Miyagi M, Wang B, Chance MR, Chen X, Du Y, Wang Y, An L, Wang Q, Lu T, Zhang X, Wang Z, Stark GR (2010) Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes
Tell your healthcare provider if you have changes in vision during treatment with Wegovy increased heart rate
Understanding GIP: The Second Incretin GIP received less attention initially than GLP-1 because early research suggested it might not be useful for diabetes treatment
GLP 1 headaches are common among people using GLP-1 medications, especially during the first few weeks of treatment or after a dose increase
Last reviewed: July 3, 2026 Last updated: July 3, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations